DEALS: Affymetrix lands ParAllele acquisition
Affymetrix lands ParAllele acquisition
|
DEALS |
|||
|
WHO |
WITH |
WHAT |
SCOOP |
|
Affymetrix |
ParAllele BioScience |
$120M buyout |
When used with Affymetrix GeneChip technology, ParAllele's proprietary assay effectively gives researchers a powerful "molecular microscope" for examining the entire genome. |
|
NBTY |
Solgar Vitamin and Herb |
$115M buyout |
Solgar manufactures and distributes nutritional supplements, including multivitamins, minerals, botanicals and specialty formulas. |
|
Qiagen |
artus Gesellschaft |
$39.2M buyout |
Artus is a leader in PCR-based molecular diagnostic tests for pathogenenic, genotyping and pharmacogenomic testing. |
|
Chromos Molecular Systems |
Targeted Molecules |
Acquisition, stock and notes |
Targeted Molecules has been focused on the research and development of two antibody product candidates for the treatment of multiple sclerosis and acute thrombosis. |
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
